These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12649674)

  • 21. h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors.
    Nucci MR; O'Connell JT; Huettner PC; Cviko A; Sun D; Quade BJ
    Am J Surg Pathol; 2001 Apr; 25(4):455-63. PubMed ID: 11257619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c-Kit expression in patients with uterine leiomyosarcomas: a potential alternative therapeutic treatment.
    Raspollini MR; Amunni G; Villanucci A; Pinzani P; Simi L; Paglierani M; Taddei GL
    Clin Cancer Res; 2004 May; 10(10):3500-3. PubMed ID: 15161707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mullerian adenosarcomas: an immunophenotypic analysis of 35 cases.
    Soslow RA; Ali A; Oliva E
    Am J Surg Pathol; 2008 Jul; 32(7):1013-21. PubMed ID: 18469708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of intermediate filaments in ovarian and uterine tumors.
    Bonazzi del Poggetto C; Virtanen I; Lehto VP; Wahlström T; Saksela E
    Int J Gynecol Pathol; 1983; 1(4):359-66. PubMed ID: 6193074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DOG1 immunoreactivity in uterine leiomyosarcomas.
    Sah SP; McCluggage WG
    J Clin Pathol; 2013 Jan; 66(1):40-3. PubMed ID: 23038686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sarcomas metastatic to the ovary: a report of 21 cases.
    Young RH; Scully RE
    Int J Gynecol Pathol; 1990; 9(3):231-52. PubMed ID: 2373588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The protooncogene c-KIT is expressed in leiomyosarcomas of the uterus.
    Raspollini MR; Paglierani M; Taddei GL; Villanucci A; Amunni G; Taddei A
    Gynecol Oncol; 2004 Jun; 93(3):718. PubMed ID: 15196872
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of oxytocin receptor expression in distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma.
    Loddenkemper C; Mechsner S; Foss HD; Dallenbach FE; Anagnostopoulos I; Ebert AD; Stein H
    Am J Surg Pathol; 2003 Nov; 27(11):1458-62. PubMed ID: 14576480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases.
    Miettinen M; Furlong M; Sarlomo-Rikala M; Burke A; Sobin LH; Lasota J
    Am J Surg Pathol; 2001 Sep; 25(9):1121-33. PubMed ID: 11688571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of CD117 (c-kit) receptor in dysgerminoma of the ovary: diagnostic and therapeutic implications.
    Sever M; Jones TD; Roth LM; Karim FW; Zheng W; Michael H; Hattab EM; Emerson RE; Baldridge LA; Cheng L
    Mod Pathol; 2005 Nov; 18(11):1411-6. PubMed ID: 16056250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uterine sarcomas.
    Mbatani N; Olawaiye AB; Prat J
    Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():51-58. PubMed ID: 30306577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Collision of endometrioid carcinoma and stromal sarcoma of the uterus: a report of two cases.
    Lam KY; Khoo US; Cheung A
    Int J Gynecol Pathol; 1999 Jan; 18(1):77-81. PubMed ID: 9891246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PDGFR-alpha as a potential therapeutic target in uterine sarcomas.
    Adams SF; Hickson JA; Hutto JY; Montag AG; Lengyel E; Yamada SD
    Gynecol Oncol; 2007 Mar; 104(3):524-8. PubMed ID: 17049587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mesenchymal and mixed uterine tumors : Current overview and practical aspects].
    Lax SF
    Pathologe; 2019 Feb; 40(1):36-45. PubMed ID: 30694356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endometrial stromal sarcoma of uterus.
    Xue WC; Cheung AN
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):719-32. PubMed ID: 21820965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myxoid Mesenchymal Tumors of the Uterus: An Update on Classification, Definitions, and Differential Diagnosis.
    Busca A; Parra-Herran C
    Adv Anat Pathol; 2017 Nov; 24(6):354-361. PubMed ID: 28787279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of imatinib mesylate-targeted kinases in endometrial carcinoma.
    Slomovitz BM; Broaddus RR; Schmandt R; Wu W; Oh JC; Ramondetta LM; Burke TW; Gershenson DM; Lu KH
    Gynecol Oncol; 2004 Oct; 95(1):32-6. PubMed ID: 15385107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution.
    Hornick JL; Fletcher CD
    Am J Clin Pathol; 2002 Feb; 117(2):188-93. PubMed ID: 11865845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myxoid endometrial stromal sarcoma of the uterus.
    Kasashima S; Kobayashi M; Yamada M; Oda Y
    Pathol Int; 2003 Sep; 53(9):637-41. PubMed ID: 14507323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Conjunctive tumors of the uterus excluding leiomyoma. Apropos of 11 cases].
    Chatti S; Kchir N; Jerbi EE; Haouet S; Mdimegh H; el Wertani L; Boubaker S; Chelli H; Zitouna MM
    Tunis Med; 1995; 73(6-7):253-7. PubMed ID: 9506174
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.